The familial aggregation indicated the inheritance of cancer risk. Recent genome-wide association studies (GWASs) have identified a number of common single-nucleotide polymorphisms (SNPs). Following heritability analyses have shown that SNPs could explain a moderate amount of variance for different cancer phenotypes among Caucasians. However, little information was available in Chinese population. We performed a genome-wide complex trait analysis for common cancers at nine anatomical sites in Chinese population (14,629 cancer cases vs. 17,554 controls) and estimated the heritability of these cancers based on the common SNPs. We found that common SNPs explained certain amount of heritability with significance for all nine cancer sites: gastric cancer (20.26%), esophageal squamous cell carcinoma (19.86%), colorectal cancer (16.30%), lung cancer (LC) (15.17%), and epithelial ovarian cancer (13.31%), and a similar heritability around 10% for hepatitis B virusrelated hepatocellular carcinoma, prostate cancer, breast cancer and nasopharyngeal carcinoma. We found that nearly or less than 25% change was shown when removing the regions expanding 250 kb or 500 kb upward and downward of the Key words: cancer, heritability, single-nucleotide polymorphisms, Chinese population, genome-wide complex trait analysis Abbreviations: LC: lung cancer; GC: gastric cancer; HCC: hepatocellular carcinoma; OC: ovarian cancer; PrC: prostate cancer; BrC: breast cancer; NPC: nasopharyngeal carcinoma; ESCC: esophageal squamous cell cancer; CRC: colorectal cancer; GWAS: genome-wide association studies; SNPs: single-nucleotide polymorphisms; GCTA: genome-wide complex trait analysis; LD: linkage disequilibrium; QC: quality control; HWE: Hardy-Weinberg equilibrium; GRM: genetic relationship matrix; BMI: body mass index Additional Supporting Information may be found in the online version of this article. J.D., W.S., W.W., J.C., T.W., and H.C. contributed equally to this work K.C., J.X., W.J., D.L., W.Z., and H.S. cosupervised this work 
Introduction
Cancer remains to be a heavy burden in both developed and developing countries. Approximately 14.1 million new cases and 8.2 million deaths emerged in 2012 worldwide according to GLOBOCAN estimates. 1 Both environmental and genetic components have been proved to contribute to cancer susceptibility. 2, 3 Previous studies have consistently demonstrated that almost every cancer exhibit familial aggregation. [4] [5] [6] [7] Twin studies have revealed a certain amount of heritability for some cancers such as lung cancer (LC) (18%), gastric cancer (GC) (22%), ovarian cancer (OC) (39%), prostate cancer (PrC) (57%), colorectal cancer (CRC) (15%), and breast cancer (BrC) (31%) in Nordic countries. 2, 8 In the past years, candidate-gene studies and genomewide association studies (GWASs) have discovered important germline variants [especially single-nucleotide polymorphisms (SNPs)] that are associated with cancer risk using case-control designs, indicating sporadic cancers bear genetic components. 9, 10 However, the variants identified so far present relatively small increments in risk, and explain only a small proportion of familial clustering (heritability). 11 The gap between the phenotypic variance explained by GWAS and those estimated by traditional heritability methods (e.g., using relatives) has been termed "missing heritability." [11] [12] [13] Several aspects could be explained for this phenomenon, including common variants with smaller effects yet to be found, rarer variants and structural variants failed to be tagged by SNPs on the genotyping arrays, and epistasis was underestimated.
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In recent years, heritability from numbers of common and rare causal variants mentioned above has been able to be estimated by genome-wide genotype data in unrelated individuals. [14] [15] [16] Estimation results for some traits and diseases (e.g., cancer) using common SNPs could partially fill the gap of "missing heritability". 15, [17] [18] [19] [20] However, most of the heritability estimations using GWAS array data were performed among European descendants. Due to the heterogeneity of different ethnics, it is necessary to explore the genetic architecture of common cancers in the Chinese population, figuring out how much heritability yet to be found using GWAS strategy in China.
In the current study, we performed a genome-wide complex trait analysis (GCTA) for nine common cancers with GWAS data in Chinese population and estimated the heritability explained by common SNPs in commercial GWAS arrays. We compared the differences of heritability between subgroups such as gender, smoking and drinking status, BMI, and age at menarche, which are well-defined risk factors for some of the cancers. We also regressed the variance partitioned by each chromosome with chromosomal length to dissect the genetic architecture among different cancer types.
Materials and Methods

Subjects
The study enrolled 32,183 individuals in total (14, informed consent, and each institutional review boards approved the corresponding procedures and experiments, respectively.
Quality control
In order to reduce the influence of technical artifacts, which may contribute to the estimation of spurious genetic variation, we implemented a more stringent quality control (QC) than standard GWAS QC strategy. 14, 18 Detailed exclusion criteria were listed as following: (1) 
Estimation of heritability
We used GCTA to estimate both of the genetic relationship matrix (GRM) of all the individuals and the heritability explained by the selected sets of autosomal SNPs (i.e., SNPs remained after stringent QC based on original GWAS commercial arrays) in restricted maximum likelihood analysis. The method developed by Yang et al.
14,30 used a mixed linear model to fit the effects of all the SNPs as random effects, regardless of whether they pass a certain significant threshold, allowing the estimation of the germline polygenetic variance. We used cancer prevalence to transform the estimated heritability from observed scale to liability scale, just as it does when estimating total heritability of liability from pedigree or twin analyses. And the cancer prevalence values in Chinese population were listed in Table S1 , which were derived from Globocan 2012 (http://globocan.iarc.fr/Pages/fact_sheets_population.aspx). Adjusted covariates in the models were consistent with original GWAS papers [LC: age, gender, and pack-year of smoking; GC, HCC, and ESCC: age, gender, and drinking and smoking status; CRC and NPC: age and gender; BrC: age, age of menarche, age at first birth, body mass index (BMI), and education status; PrC: age; OC: age]. Top 20 eigenvectors were also adjusted for population stratification in each cancer separately.
To estimate the heritability attributable to discovered loci by GWAS and also undiscovered loci, we identified SNPs in National Human Genome Research Institute catalog (https:// www.genome.gov/gwastudies/) that were associated with a given cancer (p < 5 3 10 28 ) (Table S2 ) and defined the known regions as 6250 kb or 500 kb of the significant SNPs. We estimated the GRMs from the SNPs on each chromosome and calculated the variance attributable to each chromosome by fitting the GRMs of all the chromosomes simultaneously. 31 Subgroup estimation for heritability was There were 9 and 15 missing subjects for smoking and drinking status of NPC, respectively. Abbreviation: NA, not available.
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also conducted according to gender and smoking and drinking status if these variables were available. The heterogeneity between subgroups was assessed using v 2 -based Cochrane's Q test. For CRC, we combined the heritability estimations from three datasets using meta-analysis based method (Fixed effect model: inverse-variance weighting).
Results
As shown in Table 1 , we analyzed heritability for cancer at nine anatomical sites in Chinese population (32,183 participants: 14,629 cancer cases vs. 17,554 controls, with CRC bearing the largest sample size of 5,623 and OC bearing the smallest sample size of 2, 196) . Except that OC and BrC were for only females, and PrC was for only males, 70.1%, 72.9%, 94.7%, 73.0%, 81.8%, and 31.5% of the subjects were males in LC, GC, HCC, NPC, ESCC, and CRC, respectively. The proportion of smoking subjects in LC, GC, HCC, NPC, and ESCC are 52.0%, 45.9%, 47.5%, 53.4%, and 60.6%, respectively. And the proportion of drinking subjects in GC, HCC, NPC, and ESCC are 40.3%, 37.6%, 44.6% and 50.6%, respectively. LC, GC, BrC, and ESCC used GWAS arrays from Affymetrix, while HCC, OC, PrC, and NPC used arrays from Illumina, and CRC used both Affymetrix and Illumina arrays. Numbers of SNPs were ranged from 230,517 to 633,296 after QC. Detailed information are described in Table 1 .
As shown in Table 2 and Figure 1 , all the nine datasets demonstrated significant genetic components for cancer phenotypic variance (p < 0.05). GC, ESCC, CRC, and LC rank the first four with heritability larger than 15% [heritability (standard error, SE): 20.26% (3.59%), 19 ). And compared with the overall heritability, nearly or <25% change were seen after removing known regions (6250 kb and 6500 kb). More obvious changes were shown for BrC (24.1%, 26.6%), NPC (21.4%, 21.2%), PrC (17.8%, 19.5%), and HCC (11.9%, 12.0%), while changes for the other five cancers were nearly or <5% (OC: 4.7%, 4.4%; ESCC: 4.2%, 6.4%; LC: 3.4%, 4.2%; CRC: 3.1%, 5.0%; GC: 3.0%, 2.6%) (Fig. 1) .
Subgroup analyses were performed according to gender, smoking and drinking status, BMI and Age of menarche if these variables were available (Table 3) . We estimated the variance explained by all the autosomal SNPs in each subgroup.
No significant heterogeneity between each groups was observed. For gender status, common SNPs on arrays are the heritability after removing SNPs within the region of 250 kb and 500 kb both upward and downward of GWAS significant SNPs (p < 5E28) for each cancer. Abbreviation: NA, not available.
explained more heritability for females than males in LC (0.243 vs. 0.153), and GC (0.336 vs. 0.227), while for NPC, the heritability was explained larger for males than females (0.158 vs. 0.084). As regard with smoking, more variance of common SNPs was seen in nonsmokers than smokers for LC (0.225 vs. 0.144), GC (0.347 vs. 0.192), and ESCC (0.272 vs. 0.187). For BrC, common SNPs explained more heritability for those women whose menarche appear at an older age (age of menarche >14).
For linear correlation analysis between variances for chromosome and chromosome length, we observed strong linear relationships between the estimate of variance explained by each chromosome and chromosome length (L C , in MB units) for LC (R 2 5 0.641, p 5 0.001) and ESCC (R 2 5 0.633, p 5 0.002) ( Table 4 and Fig. 2) . Conditioning on the chromosomal length, it showed that chromosome 6 and 3 explains the largest variation for LC and ESCC, respectively. And both diseases showed a smaller proportion of variance explained by chromosome 1. For NPC and CRC, the chromosomal model failed to constrain, no relationship matrixes were available. No significant correlations were observed for other five cancer types.
Discussion
The goal of the current study is to explore the amount of genetic variation that can be explained by common SNPs on Commercial arrays and further dissect the genetic architecture of nine common cancers in Chinese population. We discovered that common SNPs explained a certain amount of heritability for GC (20.26%), ESCC (19.86%), CRC (16.30%), LC (15.17%), and OC (13.31%), and a heritability of around 10% for PrC (11.20%), HCC (10.55%), NPC (10.34%), and BrC (10.19%). Analogous to other studies for heritability of cancer, we found either known SNPs or known regions (6250 kb or 500 kb from the known SNPs) from previous GWAS partitioned a small variance (the value were obtained through subtracting the variance excluding known regions from the total variance). These results partially filled the gap of heritability estimations for cancer in Chinese population and indicated that additional loci should be discovered by interrogation of increasingly larger studies in the future. The heritability estimated in our study is different from that of traditional heritability estimation methods [e.g., pedigree (twin) and full-sibling (within-family) studies]. We here estimated narrow-sense heritability (additive heritability) dependent on the linkage disequilibrium (LD) relationship between genotyped germline SNPs and casual variants, 14 while the twin and within-family studies estimate total heritability including both additive and nonadditive effects or also confounded by environmental variation. The within-family design is based on LD produced by the inheritance of large chromosome segments from parents to offspring within a family so the SNPs track all causal variants. 32 However, estimates here only consist of those common variants in LD with the SNPs genotyped on the chips as well as those passed QC. We have expected that some heritability was still missing compared to the relatively small variance explained by known regions in GWAS, coming from the causal variants not tagged by the SNPs here. 11, 16 When compared with heritability estimated by other studies, an obvious distinction was seen for PrC (0.11 in our data vs. 0.81 or 0.38 in other studies) and OC (0.13 in our data vs. 0.30 in other study) ( Table 2 ). The possible explanation should be that the incidence rate and prevalence of PrC and OC are much higher in Caucasian population than in Chinese population, 1, 33 which may indicate genetic specificities except different proportion of prostate-specific antigen screening or dietary habits for PrC, 34 and different distribution of obesity, exogenous and endogenous hormonal exposures, exposure to radiation, and caffeine consumption for OC. For example, prevalence of BRCA1 or BRCA2 mutation (important genetic risk factors for OC) differs significantly among race/ ethnic groups, which is much lower in Chinese or Asian population. 35, 36 These results reconfirmed the genetic discrepancy among different ancestries. In addition, stages, malignancy degree and proportion of subtypes in cancer cases also result in discrepant estimates of heritability. Lu et al. calculated heritability for predominantly invasive epithelial OC, while the cases in our study were epithelial OC with a different proportion of subtypes. 24, 37 Following subgroup results revealed that people who carried negative cancer risk factors (e.g., nonsmokers, nondrinkers, and older age of menarche) had the trend to explain larger amount of heritability (but there is no significance for the heterogeneity of subgroups), which also implied that multiple factors were interacted in the process of carcinogenesis. Finally, diversity in age of diagnosis of the cancer cases will also lead to different heritability estimates. As a result, our results should be generalized with caution even within the same origin of population.
Generally, known GWAS -identified risk regions explain a rather small proportion of variance in the nine common cancers (nearly or <25% changes were shown when removing the SNPs within 250 kb or 500 kb of the known variants on either direction). These findings were consistent with those reported by some other studies for cancers 17, 38 or other traits. 15, 39, 40 As compared with the much larger variance partitioned by all the common SNPs on the arrays, it indicated that additional loci with low allele frequency could be detected if we use large-scale samples. 41, 42 The results estimated by common SNPs could partially fill the gap of "missing heritability," which means heritability is not missing but hidden. Also intriguingly, we found changes after removing SNPs within 500 kb of known variants varied among cancers. BrC changes the greatest with 26.6% decrease, followed by NPC (21.1%) and PrC (19.5%). The possible reason is more SNPs from breast and PrC GWASs have been discovered, for example, nearly 90 variants have been discovered for BrC and PrC, respectively. On the other hand, heterogeneity exists among different cancers. For instance, although only nine variants 27, 43, 44 have so far been discovered associated with nasopharyngeal cancer, a disease mostly occurs in Southern China, 45 they (250 kb and 500 kb up and downwards expanded) seem to explain larger proportion of the overall heritability (21.4% and 21.1%). However, as regard with some more common cancers in various populations such as OC, ESCC, LC, and GC, more Chinese-specific causal variants are yet to be found.
Linear relationships between chromosomal length and heritability were presented, especially for LC and ESCC. This indicates that there are many polymorphisms affecting these cancers and there exists imparity of heritability in those chromosomes with different lengths (slightly increase of variance with larger length of chromosomes). Yang et al. 31 has provided the evidence that the linear relationship cannot be due to the fact that longer chromosomes have more SNPs and thus smaller sampling errors when estimating genetic relationships between individuals. Although it is statistically significant, the linear relationship of the two cancers between the estimates of variances explained and genomic length is not so perfect. Heritability explained by chromosomal 17, 6, and 3 positively deviated from the linear relation for LC and esophageal squamous cell carcinoma, respectively, while heritability of chromosome 1 negatively deviated for both cancers. For chromosome 7, larger variance was explained for esophageal squamous cell carcinoma, but not for LC. For chromosome 12, much smaller variance was explained for LC, which was, however, converse for ESCC. Besides, chromosomes with similar lengths can explain different amounts of variation for the same cancer. It is possible that mutate rate differs among chromosomes, and certain chromosomes bear larger numbers or larger effects of mutations towards tendency for different cancers. 46 Further evidences should be provided for the two types of cancer, especially for those chromosomes bearing larger variances. Our study here provided further evidence for the highly polygenic nature of cancer as well as the heterogeneity among cancers.
We successfully estimated the array based heritability and found the polygenic genetic architecture of common cancers for Chinese population. However, there were also some limitations in the current study. Firstly, although we analyzed the most common cancers in Chinese population with an overall large sample size, the sample size was relatively small for each cancer, especially in specific subgroups, which may result in limited statistical power to estimate the relationship matrix in chromosomal model. Secondly, cancer prevalence for specific subgroups such as smokers, nonsmokers, drinkers and nondrinkers were not available among Chinese population, which possibly introduce bias in subgroup analyses. Thirdly, the criteria for QC may be too stringent, especially for HWE. More SNPs have been removed under this criteria, which may lead to insufficient representativeness of SNPs and heritability estimations for some cancers (for example, 66% of the array SNPs were removed after QC for GC). Finally, it might be interesting to explore whether the SNPs in or around genes and the intergenic SNPs explain different variation. This might be the next step of our research. In summary, to our knowledge, this is the first attempt to explore the heritability of nine cancer types using GWAS strategy in Chinese population. These results indicate polygenic genetic architecture of the nine common cancers in Chinese population and more efforts should be made to discover the hidden heritability by interrogation of increasingly larger studies in the future.
